These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 13678320)

  • 1. Stability of mycophenolic acid in plasma samples from patients during mycophenolate mofetil therapy.
    Pawiński T; Shaw LM
    Acta Pol Pharm; 2003; 60(2):121-4. PubMed ID: 13678320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal storage temperature and matrix before analyzing mycophenolic acid.
    Tracey J; Brown NW; Tredger JM
    Ther Drug Monit; 2012 Apr; 34(2):148-52. PubMed ID: 22377748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
    Jain AB; Hamad I; Zuckerman S; Zhang S; Warty VS; Fung JJ; Venkataramanan R
    Liver Transpl Surg; 1999 Mar; 5(2):101-6. PubMed ID: 10071348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of mycophenolate mofetil as an extemporaneous suspension.
    Venkataramanan R; McCombs JR; Zuckerman S; McGhee B; Pisupati J; Dice JE
    Ann Pharmacother; 1998; 32(7-8):755-7. PubMed ID: 9681090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.
    Tedesco-Silva H; Bastien MC; Choi L; Felipe C; Campestrini J; Picard F; Schmouder R
    Transplant Proc; 2005 Mar; 37(2):852-5. PubMed ID: 15848554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
    Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A
    Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
    Kaplan B
    Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of mycophenolic acid and its glucuronide after a single and multiple oral dose of mycophenolate mofetil in Chinese renal transplantation recipients.
    Liang MZ; Lu YP; Nan F; Li YP
    Transplant Proc; 2006 Sep; 38(7):2044-7. PubMed ID: 16979994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The magnitude and time course of changes in mycophenolic acid 12-hour predose levels during antibiotic therapy in mycophenolate mofetil-based renal transplantation.
    Borrows R; Chusney G; Loucaidou M; James A; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Ther Drug Monit; 2007 Feb; 29(1):122-6. PubMed ID: 17304160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD
    Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients.
    van Hest RM; Doorduijn JK; de Winter BC; Cornelissen JJ; Vulto AG; Oellerich M; Löwenberg B; Mathot RA; Armstrong VW; van Gelder T
    Ther Drug Monit; 2007 Jun; 29(3):353-60. PubMed ID: 17529894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of mycophenolic acid can be used as predictor of clinical events for kidney transplant recipients treated with mycophenolate mofetil.
    Lu YP; Zhu YC; Liang MZ; Nan F; Yu Q; Wang L; Wang J; Li YP
    Transplant Proc; 2006 Sep; 38(7):2048-50. PubMed ID: 16979995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
    Jirasiritham S; Sumethkul V; Mavichak V; Na-Bangchang K
    Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
    Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a CE method for the determination of mycophenolic acid in human plasma: a comparison with HPLC.
    Carlucci F; Anzini M; Rovini M; Cattaneo D; Merlini S; Tabucchi A
    Electrophoresis; 2007 Nov; 28(21):3908-14. PubMed ID: 17922503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.
    Tredger JM; Brown NW; Adams J; Gonde CE; Dhawan A; Rela M; Heaton N
    Liver Transpl; 2004 Apr; 10(4):492-502. PubMed ID: 15048791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.
    Brunet M; Cirera I; Martorell J; Vidal E; Millán O; Jiménez O; Rojo I; Londoño MC; Rimola A
    Transplantation; 2006 Feb; 81(4):541-6. PubMed ID: 16495801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.